CannTrust Holdings Inc.
Most Recent
Coronavirus Revealed Cannabis Supply Chain’s Pitfalls
The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain.
Mississippi Lawmakers Make Marijuana Legalization Harder
Mississippi has been trying to put a legalization initiative on the November ballot. However, lawmakers’ new strategy makes legalization difficult.
Exploring Canada’s Cannabis Demand-Supply Landscape
Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.
Why Cannabis Stocks Are Falling Today
Weakness in cannabis stocks continued today, the fourth day of decline. The US equity market fell today due to the growing tension between the US and Iran.
Cannabis Investment: How to Buy ACB, CGC, and Other Stocks
Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.
Why Is CannTrust Experiencing a Rally in 2020?
CannTrust (CTST) stock has experienced a surprising turn of events in January. The stock has gained good upward momentum.
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
Cannabis Sector 2019 Review and 2020 Outlook
Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.
CannTrust Receives NYSE Listing Compliance Notice
Beleaguered cannabis company CannTrust (CTST)(TRST) received a notice from the NYSE that the company is no longer in compliance with its listing rules.
Cannabis Update: GTII, KSHB, IIPR, and CTST
Today, the cannabis sector was trading in the red, with multiple ETFs losing ground. Here, we’ll have a look at cannabis stocks that are in the news today.
Regulators Beware: Cannabis Linked to Job Loss
Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
Why Republicans Don’t Push for Cannabis Legalization
Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.
Cannabis Sales Decline Across Canada—Why?
In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.
CannTrust Lands in Hot Water Again
The Canadian cannabis company CannTrust (CTST) announced that the Toronto Stock Exchange is reviewing the company’s listing.
Bank of America Upgrades Canopy Growth to ‘Buy’
Canopy Growth (WEED)(CGC) got a rare upgrade to “buy” from Bank of America today. Find out what drove the change—and what’s next.
Illegal Cannabis: A Big Problem for Legal Producers
Despite Canada’s legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.
Did HEXO Get Itself into a Licensing Scandal?
Last week, HEXO Corporation (HEXO) issued a press release that provided more information about its Niagara facility license.
Why CannTrust Is on a Long Road to Recovery
CannTrust (CTST) stock is gradually recovering after it hit an all-time low of $0.82 last month. However, the worst for the company isn’t over yet.
HEXO: Legal Cannabis Might Not Kill Illegal Market
In the fourth-quarter earnings call, HEXO discussed how it thinks that legal cannabis won’t solve the problem with the illegal market in Canada.
Cannabis: Kraft Heinz Marks Warren Buffett’s Entry
Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.
Cannabis Update: HEXO, CTST, APHA, and ACB
At 12:51 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were up 0.5% and 0.7%, respectively. The cannabis sector was also up today.
Smokable Hemp: Banned in North Carolina in May 2020
When May 1, 2020, rolls around, you’ll won’t be able to smoke hemp in North Carolina legally. Just yesterday, the North Carolina House passed the North Carolina Farm Act with revisions to restrict smokable hemp. Why was it banned? The smokable hemp ban was widely supported by law enforcement agencies. Law enforcement officers might find […]
Valuation for Cannabis Stocks in October
The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.
CannTrust Is Up after Falling below $1
Today CannTrust Holdings is trading at $1.30 on the NYSE, 25.60% higher than its last closing price. It’s risen even faster on the Toronto Stock Exchange.
Cannabis Stocks in the Green: APHA, WEED, CTST, ACB
With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let’s take a closer look.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
HEXO: The Next Cannabis Player on the Scandal Radar?
By the end of September, HEXO was one of the few cannabis companies to have delivered positive returns in 2019. However, this month has been tough.
Cannabis Scandal Radar: Is Tilray Next?
Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?
Cannabis Sector: Week Ended October 10 in Review
The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.
Cannabis Stocks: Will Tough Times End Soon?
Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.
Cannabis Roundup: KSHB, WEED, CTST, and CURA
Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.
Aphria: Analysts’ Target Price and Ratings
While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.
CannTrust Stock Hits an All Time Low: What’s Next?
CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.
Which Cannabis Stocks Have Lost More than 40% in 2019?
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Marijuana Legalization: O’Rourke Blazes His 2020 Campaign
Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.
Cannabis Roundup: CTST, CURA, CRON, and WEED
Today, the US cannabis markets were trading a little higher than we have seen in the recent past. The Federal Reserve cut interest rates by 25 points.
Canopy Growth Stock Rises, Oppenheimer Initiates Coverage
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
Cannabis: House to Vote on US Banking Bill
The SAFE Banking Act is gaining traction again, as House Majority Leader Steny Hoyer is expected to bring the banking bill to the House floor for a vote.
CannTrust Loses License: Will It Fall below $1?
CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.
Cannabis Roundup: MMEN, ACB, WEED, and CTST
Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.
Marijuana: Will Trump Have an Edge over Biden?
With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.
Cannabis Legalization: Dark Clouds Loom Post Debate
Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.
CannTrust: Eight Capital Removed Its Target Price
On Tuesday, Eight Capital removed its target price for CannTrust Holdings due to uncertainty about the risks involved in the company’s future operations.
Tilray: Are Analysts Optimistic about Its Stock?
After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.
CannTrust Down Almost 65% in 2019—What’s Next?
On September 6, CannTrust Holdings (TRST) (CTST) was trading at 2.33 Canadian dollars. This marked a discount of 85% from its 52-week high.
Cannabis Roundup: CTST, CRON, OGI, ACB, and WEED
Cannabis ETFs the ETFMG Alternative Harvest ETF and the Horizons Marijuana Life Sciences Index ETF were up 2.0% and 1.7%, respectively, at 1:20 PM today.
Cannabis Roundup: WEED, ACB, ACRGF, and CTST
News that the US and China plan to revive trade talks in October boosted the US stock market. Most of the cannabis players traded in the green today.
New Cannabis Products to Follow Edibles Legalization
Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.
HEXO: What’s the Word on the Street?
HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.
CannTrust: The Bad News Keeps Pouring In
CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive
How Cannabis ETFs HMMJ, MJ, TOKE Looked in August
In the wake of its regulatory scandals, the cannabis sector lagged the equity market in August. YTD, MJ and HMMJ have fallen 3.7% and 1.5%, respectively.
Cronos: What’s the Word on Wall Street?
Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.
Cannabis Legalization: Did President Trump Drop a Hint?
Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.
Opioid Crisis: Is Cannabis Legalization a Good Idea?
According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.
Marijuana: Why Is Washington Changing Its Laws?
In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.
Aurora Cannabis: What’s the Word on the Street?
Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.
OrganiGram: Lower Target Price and Valuation Multiple
Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.
Canopy Growth Gets an Upgrade, Constellation Books Losses
Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”
Marijuana and Trade War: Will Democrats’ Agenda Intensify?
The trade war might impact the marijuana industry. The US-China trade war has been an ongoing issue. President Trump imposed tariffs on China in May.
Cresco Labs: Target Price and Valuation Multiple
Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”
MedMen Fires Up to Make Marijuana Legal in Florida
MedMen (MMNFF) (MMEN) closed 1.9% higher on Thursday. The company launched a 2020 ballot initiative called “Make it Legal Florida.”
HEXO: What Does Jim Cramer Think?
HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.
Can Marijuana Legalization Spark Beto O’Rourke’s Bid?
Marijuana reform is central to Beto O’Rourke’s 2020 presidential campaign—how could his agenda that affect the cannabis industry?
Marijuana: What Do Buffett and the Richest Americans Think?
Marijuana is a hot topic right now! From presidential candidates to the wealthiest Americans, everyone is talking about the sector.
Jim Cramer: Cronos and Aphria Passed Canopy Growth
On Tuesday, Jim Cramer stated that Cronos Group and Aphria passed Canopy Growth. Canopy Growth has lost 15.3% of its stock value since its Q1 earnings.
Why Is Cresco Labs Tanking ahead of Its Q2 Results?
Cresco Labs (CRLBF) is all set to report its second-quarter results after the market closes today. Cresco stock tanked 6.9% yesterday.
Could Bill de Blasio Help the Cannabis Industry?
In May, NYC mayor Bill de Blasio announced he was running for the 2020 Democratic presidential nomination. Initially, he was against legalizing cannabis.
Cannabis Industry: FBI Investigation Poses Challenges
The cannabis industry has been in the spotlight this year, and now the FBI is investigating allegations of corruption in this nascent industry.
MedMen Launches Cannabis Delivery Service in the US
MedMen (MMNFF) closed almost 6% higher on Monday. The company announced the launch of its new California-wide delivery service for cannabis.
Bernie Sanders Tweets on Marijuana Legalization
Bernie Sanders tweeted his support for legalizing marijuana nationally and expunging past marijuana convictions. How could this impact cannabis stocks?
Canopy Growth Falls to Its Lowest Point in 2019
Today, Canopy Growth (WEED) (CGC) stock saw its lowest point in 2019. The stock opened at $28.3 but fell to $26.5 in the afternoon.
Cannabis Industry: FBI and FDA Tighten the Screws
Cannabis companies face regulatory challenges. Recently, CannTrust (CTST) didn’t comply with Health Canada’s regulations.
HEXO: Lower Target Price and Valuation Multiple
As of August 13, HEXO (HEXO) was trading at 6.51 Canadian dollars—a fall of 30.9% since its third-quarter earnings on June 12.
Cresco Labs Stock Tumbling ahead of Earnings
Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.
Canopy Growth Earnings Impacted the Cannabis Sector
Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.
Aurora Cannabis Is Upsizing Its Secured Credit Facility
Aurora Cannabis (ACB) announced that it’s increasing its secured credit facility to 360 million Canadian dollars from $200 million Canadian dollars.
Why Mike Tyson Is Talking about Cannabis
CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.
Canopy Growth: What to Expect from Its Earnings Today
Canopy Growth (CGC) (WEED) is scheduled to announce its results for the first quarter of fiscal 2020 after the market closes on Wednesday.
IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.
CannTrust: Current Target Price and Valuation Multiple
As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.
Tilray: What to Expect from Its Q2 Earnings Today
Tilray (TLRY) is scheduled to release its second-quarter results today after the market closes. Lately, Tilray stock has been off the radar.
Cresco Labs Lands New York Deal before Earnings
Cresco Labs is due to report its Q2 earnings on August 21 after the market closes. A week ahead, it received regulatory approval for a New York deal.
CannTrust: More Compliance Issues, Stock Fell
Early on Monday, CannTrust (CTST) fell almost 26.8%. The development came after Health Canada found more areas that didn’t comply with regulations.
IIPR’s Q2 Earnings Call: Key Takeaways for Investors
So far, Innovative Industrial Properties (IIPR) stock has been impressive in 2019. The stock has gained almost 126% year-to-date.
Why Is CannTrust Falling on Friday?
CannTrust (CTST), a popular name in the cannabis sector, has been falling on Friday. The stock has fallen 6.2% as of 10:51 AM ET.
Why Jim Cramer Favors CRON and CGC
Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.
Joe Biden Wants to Reform Cannabis Laws
Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”
Is Aphria Eyeing CannTrust’s Assets?
Aphria (APHA) had stellar Q4 earnings results. Its operating metrics significantly improved, turning its bottom line positive.
CannTrust: The Pain Grows on a Daily Basis
The Ontario Securities Commission opened an investigation into CannTrust’s alleged activities related to violation of Health Canada’s regulations.
Aphria Falls before 4Q and Fiscal 2019 Earnings
On Thursday, Aphria (APHA) is scheduled to release its fourth-quarter and fiscal 2019 earnings results after the market closes.
Miracle-Gro, CannTrust, Emerald Health Stocks Surging
Scotts Miracle-Gro (SMG) reported its earnings this morning. Now SMG is surging alongside CannTrust and Emerald Health stocks. Here’s why.
SMG Stock’s Cannabis Bet Is Paying Off
SMG stock became hot last year with other core cannabis stocks like Canopy Growth (WEED) (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).
CannTrust and HEXO Try to Calm Investors
CannTrust and HEXO have tried to calm investors after facing controversy. However, CTST and HEXO stock movement suggests investors aren’t convinced.
What Analysts Expect for Aphria’s Earnings
Aphria (APHA) is set to announce its fiscal 2019 fourth-quarter results on Thursday. Analysts expect the company’s sales to grow 47% sequentially.
CRON Stock: Target Price and Valuation Update
CRON stock has lost almost 11% in July. With only two more trading days left in the month, the stock will likely end in the negative territory.
Why HEXO Stock Fell Almost 18% Last Week
HEXO (HEXO) stock lost nearly 18% in the week ending July 26. There weren’t any catalysts that showed weakness in the stock.
Why CannTrust Jumped 15% (Hint: Damage Control)
On July 25, CannTrust stock jumped almost 15% after the market closed driven by the company’s announcement of leadership changes.
Aurora Cannabis: Target Price and Valuation Update
So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]